AMERISAFE (AMSF) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
24 Apr, 2026Executive summary
Annual meeting scheduled for June 10, 2026, at corporate headquarters in DeRidder, Louisiana.
Shareholders will vote on director elections, executive compensation, auditor ratification, officer exculpation, and technical amendments to the Certificate of Formation.
Record date for voting is April 16, 2026, with 18,703,771 shares outstanding.
Board recommends voting in favor of all proposals.
Voting matters and shareholder proposals
Election of three directors for terms expiring in 2029: Michael J. Brown, G. Janelle Frost, and Sean M. Traynor.
Advisory vote on executive compensation (say-on-pay).
Ratification of Ernst & Young LLP as independent auditor for 2026.
Approval of officer exculpation amendment to limit personal liability of officers.
Approval of technical and conforming amendments to the Certificate of Formation, including updates to special meeting rights and registered agent information.
Shareholder proposals for the 2027 meeting must be received by December 28, 2026.
Board of directors and corporate governance
Board consists of seven non-employee and one employee director, divided into three classes with staggered three-year terms.
All non-employee directors are independent under NASDAQ rules.
Board committees: Audit, Compensation, Nominating and Corporate Governance (NCG), and Risk Committee.
Directors are subject to stock ownership and retention guidelines; all are in compliance.
Board emphasizes diversity, with 25% women and 25% racially diverse members.
Succession planning and shareholder communications are formalized.
Latest events from AMERISAFE
- Net premiums earned rose 9.0%, but net income fell as underwriting costs and competition increased.AMSF
Q1 202623 Apr 2026 - Annual meeting to address director elections, pay, auditor, exculpation, and governance updates.AMSF
Proxy filing14 Apr 2026 - High-hazard workers' comp specialist with strong underwriting, capital returns, and safety focus.AMSF
Investor presentation9 Apr 2026 - Premiums and policy count rose 10.2%, but net income fell 15% as loss severity increased.AMSF
Q4 20259 Apr 2026 - Net income fell as higher loss expenses offset premium growth, but capital returns remained strong.AMSF
Q2 20242 Feb 2026 - Q3 net income rose 43.8% to $14.3M, with strong premium growth and a $3.00 dividend declared.AMSF
Q3 202418 Jan 2026 - Net income dropped 47% as investment returns fell, despite higher premiums and strong retention.AMSF
Q1 202527 Dec 2025 - Net income reached $55.4M with 20.2% ROE, premium growth, and a 5.4% dividend increase.AMSF
Q4 202423 Dec 2025 - Annual meeting to vote on directors, pay, auditor, and director stock plan amendment.AMSF
Proxy Filing1 Dec 2025